Lanreotide/octreotide/sunitinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1911卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17556-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：259 / 259

相关论文

共 50 条

[21] Octreotide/steroidsLack of efficacy: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 610 - 610
[22] Octreotide/PasireotideLack of efficacy : case report
[J]. Reactions Weekly, 2024, 2019 (1) : 363 - 363
[23] Octreotide/pantoprazoleLack of efficacy: case report
[J]. Reactions Weekly, 2024, 2021 (1) : 431 - 431
[24] Octreotide/pancreatinLack of efficacy: case report
[J]. Reactions Weekly, 2023, 1966 (1) : 291 - 291
[25] Octreotide/orlistatLack of efficacy: case report
[J]. Reactions Weekly, 2021, 1846 (1) : 249 - 249
[26] Octreotide/prednisoloneLack of efficacy: case report
[J]. Reactions Weekly, 2023, 1972 (1) : 283 - 283
[27] SunitinibLack of efficacy: 11 case reports
[J]. Reactions Weekly, 2023, 1944 (1) : 518 - 518
[28] Imatinib/sunitinibLack of efficacy, membranous nephropathy and chronic thrombotic microangiopathy: case report
[J]. Reactions Weekly, 2023, 1954 (1) : 237 - 237
[29] Imatinib/sunitinibLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1889 (1) : 167 - 167
[30] SunitinibLack of efficacy
[J]. Reactions Weekly, 2024, 2002 (1) : 430 - 430

← 1 2 3 4 5 →